Crokaert F, Blogie M, Prigoginc T, Yourassowsky E
a Hopital Universitaire Brugmann , departcment de Biologic Clinique , avenue J .J. CrocqI, 1020 Bruxelles.
Acta Clin Belg. 1980 Jan;35(3):127-39. doi: 10.1080/22953337.1980.11718735.
114 strains isolated by blood cultures and transtracheal aspirations were typed: serotypes 3 and 4 were largely predominant and a 14-valent vaccine (1, 2, 3, 4, 6, 8, 9, 12, 14, 19, 23, 25, 51, 56) should cover 67 % of these strains and protect 53 % of our patients because the efficacy of the vaccine is evaluated at 80 %. A controlled clinical trial seems to be necessary. We did not isolate any penicillin-resistant strain but 14 % of our strains were resistant to tetracycline.
对通过血培养和经气管抽吸分离出的114株菌株进行了分型:血清型3和4占主导地位,一种14价疫苗(1、2、3、4、6、8、9、12、14、19、23、25、51、56)应能覆盖这些菌株的67%,并保护53%的患者,因为疫苗的疗效评估为80%。似乎有必要进行一项对照临床试验。我们没有分离出任何对青霉素耐药的菌株,但我们的菌株中有14%对四环素耐药。